Works matching AU Huang, Yi-Hsiang

Results: 177
    1
    2
    3

    Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

    Published in:
    Liver International, 2016, v. 36, n. 12, p. 1755, doi. 10.1111/liv.13253
    By:
    • Su, Tung ‐ Hung;
    • Hu, Tsung ‐ Hui;
    • Chen, Chi ‐ Yi;
    • Huang, Yi ‐ Hsiang;
    • Chuang, Wan ‐ Long;
    • Lin, Chun ‐ Che;
    • Wang, Chia ‐ Chi;
    • Su, Wei ‐ Wen;
    • Chen, Ming ‐ Yao;
    • Peng, Cheng ‐ Yuan;
    • Chien, Rong ‐ Nan;
    • Huang, Yi ‐ Wen;
    • Wang, Horng ‐ Yuan;
    • Lin, Chih ‐ Lin;
    • Yang, Sheng ‐ Shun;
    • Chen, Tsung ‐ Ming;
    • Mo, Lein ‐ Ray;
    • Hsu, Shih ‐ Jer;
    • Tseng, Kuo ‐ Chih;
    • Hsieh, Tsai ‐ Yuan
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma– with Emphasis on Locoregional Therapy for Oligoprogression.

    Published in:
    Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 509, doi. 10.1159/000536549
    By:
    • Liu, Tsung-Hao;
    • Chen, San-Chi;
    • Rau, Kun-Ming;
    • Lu, Li-Chun;
    • Lin, Po-Ting;
    • Su, Yung-Yeh;
    • Teng, Wei;
    • Lai, Shiue-Wei;
    • Yeh, Ren-Hua;
    • Kao, Tsui-Mai;
    • Lee, Pei-Chang;
    • Wu, Chi-Jung;
    • Chen, Chien-Hung;
    • Hsu, Chih-Hung;
    • Lin, Shi-Ming;
    • Huang, Yi-Hsiang;
    • Chen, Li-Tzong;
    • Cheng, Ann-Lii;
    • Shen, Ying-Chun
    Publication type:
    Article
    12
    13

    Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 426, doi. 10.1159/000525582
    By:
    • Yau, Thomas;
    • Tai, David;
    • Chan, Stephen Lam;
    • Huang, Yi-Hsiang;
    • Choo, Su Pin;
    • Hsu, Chiun;
    • Cheung, Tan To;
    • Lin, Shi-Ming;
    • Yong, Wei Peng;
    • Lee, Joycelyn;
    • Leung, Thomas;
    • Shum, Tracy;
    • Yeung, Cynthia S.Y.;
    • Tai, Anna Yin-Ping;
    • Law, Ada Lai Yau;
    • Cheng, Ann-Lii;
    • Chen, Li-Tzong
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals.

    Published in:
    Viruses (1999-4915), 2022, v. 14, n. 2, p. 333, doi. 10.3390/v14020333
    By:
    • Chen, Yen-Chun;
    • Chang, Te-Sheng;
    • Chen, Chien-Hung;
    • Cheng, Pin-Nan;
    • Lo, Ching-Chu;
    • Mo, Lein-Ray;
    • Chen, Chun-Ting;
    • Huang, Chung-Feng;
    • Kuo, Hsing-Tao;
    • Huang, Yi-Hsiang;
    • Tai, Chi-Ming;
    • Peng, Cheng-Yuan;
    • Bair, Ming-Jong;
    • Yeh, Ming-Lun;
    • Lin, Chih-Lang;
    • Lin, Chun-Yen;
    • Lee, Pei-Lun;
    • Chong, Lee-Won;
    • Hung, Chao-Hung;
    • Huang, Jee-Fu
    Publication type:
    Article
    25
    26

    Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211010937
    By:
    • Jun, Tomi;
    • Ozbek, Umut;
    • Dharmapuri, Sirish;
    • Hardy-Abeloos, Camille;
    • Zhu, Huili;
    • Lin, Jung-Yi;
    • Personeni, Nicola;
    • Pressiani, Tiziana;
    • Nishida, Naoshi;
    • Lee, Pei-Chang;
    • Lee, Chieh-Ju;
    • Hildebrand, Hannah;
    • Nimkar, Neil;
    • Paul, Sonal;
    • Fessas, Petros;
    • Naeem, Muntaha;
    • Bettinger, Dominik;
    • Khan, Uqba;
    • Saeed, Anwaar;
    • Huang, Yi-Hsiang
    Publication type:
    Article
    27

    Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211010937
    By:
    • Jun, Tomi;
    • Ozbek, Umut;
    • Dharmapuri, Sirish;
    • Hardy-Abeloos, Camille;
    • Zhu, Huili;
    • Lin, Jung-Yi;
    • Personeni, Nicola;
    • Pressiani, Tiziana;
    • Nishida, Naoshi;
    • Lee, Pei-Chang;
    • Lee, Chieh-Ju;
    • Hildebrand, Hannah;
    • Nimkar, Neil;
    • Paul, Sonal;
    • Fessas, Petros;
    • Naeem, Muntaha;
    • Bettinger, Dominik;
    • Khan, Uqba;
    • Saeed, Anwaar;
    • Huang, Yi-Hsiang
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Large‐scale genome‐wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 4, p. 682, doi. 10.1111/apt.15887
    By:
    • Huang, Yu‐Han;
    • Liao, Shu‐Fen;
    • Khor, Seik‐Soon;
    • Lin, Yu‐Ju;
    • Chen, Hsuan‐Yu;
    • Chang, Ya‐Hsuan;
    • Huang, Yi‐Hsiang;
    • Lu, Sheng‐Nan;
    • Lee, Hye‐Won;
    • Ko, Wen‐Ya;
    • Huang, Claire;
    • Liu, Po‐Chun;
    • Chen, Yen‐Ju;
    • Wu, Ping‐Feng;
    • Chu, Hou‐Wei;
    • Wu, Pei‐Ei;
    • Tokunaga, Katsushi;
    • Shen, Chen‐Yang;
    • Lee, Mei‐Hsuan
    Publication type:
    Article
    38

    Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1290, doi. 10.1111/apt.15011
    By:
    • Liu, Chen‐Hua;
    • Yu, Ming‐Lung;
    • Peng, Cheng‐Yuan;
    • Hsieh, Tsai‐Yuan;
    • Huang, Yi‐Hsiang;
    • Su, Wei‐Wen;
    • Cheng, Pin‐Nan;
    • Lin, Chih‐Lin;
    • Lo, Ching‐Chu;
    • Chen, Chi‐Yi;
    • Chen, Jyh‐Jou;
    • Ma, Qian;
    • Brooks‐Rooney, Craig;
    • Kao, Jia‐Horng
    Publication type:
    Article
    39
    40
    41
    42
    43

    Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice.

    Published in:
    BioMed Research International, 2019, p. 1, doi. 10.1155/2019/6740616
    By:
    • Tsai, Hung-Cheng;
    • Chang, Fu-Pang;
    • Li, Tzu-Hao;
    • Liu, Chih-Wei;
    • Huang, Chia-Chang;
    • Huang, Shiang-Fen;
    • Yang, Ying-Ying;
    • Lee, Kuei-Chuan;
    • Hsieh, Yun-Cheng;
    • Wang, Ying-Wen;
    • Lee, Tzung-Yan;
    • Huang, Yi-Hsiang;
    • Hou, Ming-Chih;
    • Lin, Han-Chieh
    Publication type:
    Article
    44

    Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 8, p. 2357, doi. 10.3109/10428194.2014.991922
    By:
    • Wu, Chia-Yun;
    • Hsiao, Liang-Tsai;
    • Chiou, Tzeon-Jye;
    • Gau, Jyh-Pyng;
    • Liu, Jin-Hwang;
    • Yu, Yuan-Bin;
    • Wu, Yi-Tsui;
    • Liu, Chia-Jen;
    • Huang, Yu-Chung;
    • Hung, Man-Hsin;
    • Chen, Po-Min;
    • Huang, Yi-Hsiang;
    • Tzeng, Cheng-Hwai
    Publication type:
    Article
    45
    46
    47
    48
    49
    50